Influenza A H5 Antigen antibody | 15A6

Haemagglutinin is an antigenic glycoprotein which allows viral attachment and entry into the cell. Sixteen subtypes of haemagglutinin (H1-H16) have been described, of which H1, H2 and H3 infect humans. H5 and H7 normally result in avian disease, with some highly pathogenic H5N1 strains causing 100% mortality in poultry. H5N1 has in some cases mutated to infect humans, with 60% mortality. Haemagglutinin is one of the most medically relevant antigens on influenza as it is a target for antiviral drugs and antibodies.
Product Details
- Target Species
- Viral
- Product Form
- Purified IgG - liquid
- Preparation
- Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
0.09% Sodium Azide (NaN3) - Immunogen
- Purified avian influenza virus type A (H5N1).
- Approx. Protein Concentrations
- IgG concentration 1.0mg/ml
- Fusion Partners
- Spleen and lymph node cells from immunised Balb/C mice were fused with cells of the Sp2/0 myeloma cell line.
Storage Information
- Storage
- Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use. - Guarantee
- 18 months from date of despatch.
More Information
- Regulatory
- For research purposes only
Applications of Influenza A H5 Antigen antibody
Application Name | Verified | Min Dilution | Max Dilution |
---|---|---|---|
ELISA |
Secondary Antibodies Available
Product Specific References
References for Influenza A H5 Antigen antibody
-
Alexander, D.J. (2000) A review of avian influenza in different bird species.
Vet. Microbiol. 22: 3-13. -
Gauthier-Clerc. M. et al. (2007) Recent expansion of highly pathogenic avian influenza H5N1: a critical review
Ibis. 149 (2): 202-14.